Sulfinpyrazone

Applications

NDAs, BLAs and generic ANDAs for this ingredient, oldest first; each opens its full history

Approved	Application	Sponsor	Supplements	Marketing
May 13, 1959	AnturaneNDA 11556 · New molecular entity	Novartis	23	Discontinued
May 26, 1982	SulfinpyrazoneANDA 87667	Watson Labs	0	Discontinued
Jun 1, 1982	SulfinpyrazoneANDA 87769	Ivax Pharms	3	Discontinued
Sep 17, 1982	SulfinpyrazoneANDA 87665	Barr	15	Discontinued
Sep 17, 1982	SulfinpyrazoneANDA 87666	Barr	19	Discontinued
Nov 19, 1982	SulfinpyrazoneANDA 87770	Ivax Pharms	12	Discontinued
Sep 6, 1985	SulfinpyrazoneANDA 88933	Par Pharm	4	Discontinued
Sep 6, 1985	SulfinpyrazoneANDA 88934	Par Pharm	5	Discontinued
—	SulfinpyrazoneANDA 88666	Vangard	1	Discontinued

Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA